Treatment of H. pylori infection: a review.

Marcello Candelli, Enrico Celestino Nista, Emilia Carloni, Giulia Pignataro, Maria Assunta Zocco, Immacolata Alessia Cazzato, Cristiana Di Campli, Lucia Fini, Giovanni Battista Gasbarrini, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

17 Citazioni (Scopus)


Helicobacter pylori infection has been indicated as the main pathogenic factor in the development of chronic gastritis, peptic ulcer disease, and gastric malignancies. Although the vast majority of infected subjects do not carry but a mild, asymptomatic gastritis, still there are some cases in which the eradication of the infection appears mandatory. This review addresses current anti-Helicobacter regimens and pharmacological resources, and highlights the pros and cons of each of them, according to the most recent and reliable clinical trials. Also, basic recommendations are given, regarding treatment choice in the event of the failure of a first or second line eradicating strategy, and about the implementation of standard regimens with newer antibacterial devices as probiotics. PMID: 15720247 [PubMed - indexed for MEDLINE]
Lingua originaleEnglish
pagine (da-a)375-384
Numero di pagine10
RivistaCurrent Medicinal Chemistry
Stato di pubblicazionePubblicato - 2005


  • helicobacter pylori


Entra nei temi di ricerca di 'Treatment of H. pylori infection: a review.'. Insieme formano una fingerprint unica.

Cita questo